Upscaling cardiac assist devices in decompensated heart failure: Choice of device and its timing

Stocker, 2007, Effects of levosimendan and milrinone on oxygen consumption in isolated guinea-pig heart, Crit Care Med, 35, 252, 10.1097/01.CCM.0000251123.70632.4E Kaheinen, 2004, Effects of levosimendan and milrinone on oxygen consumption in isolated guinea-pig heart, J Cardiovasc Pharmacol, 43, 555, 10.1097/00005344-200404000-00011 Mishra, 2006, Role of prophylactic intra-aortic balloon pump in high-risk patients undergoing percutaneous coronary intervention, Am J Cardiol, 98, 608, 10.1016/j.amjcard.2006.03.036 Naidu, 2011, Novel percutaneous cardiac assist devices. The science of and indications for hemodynamic support, Circulation, 123, 533, 10.1161/CIRCULATIONAHA.110.945055 Thomas, 2010, Use of a percutaneous left ventricular assist device for high risk cardiac interventions and cardiogenic shock, J Invasive Cardiol, 22, 360 Dixon, 2009, A prospective feasibility trial investigating the use of Impella 2.5 system in patients undergoing high-risk percutaneous coronary intervention (the PROTECT I trial), JACC Cardiovasc Interv, 2, 91, 10.1016/j.jcin.2008.11.005 Dangas, 2014, Impact of hemodynamic support with Impella 2.5 versus intra-aortic balloon pump on prognostically important clinical outcomes in patients undergoing high-risk percutaneous coronary intervention (from the PROTECT II randomized trial), Am J Cardiol, 113, 222, 10.1016/j.amjcard.2013.09.008 Nichol, 2006, Systematic review of percutaneous cardiopulmonary bypass for cardiac arrest or cardiogenic shock states, Resuscitation, 70, 381, 10.1016/j.resuscitation.2006.01.018 Jaski, 2010, A 20-year experience with urgent percutaneous cardiopulmonary bypass for salvage of potential survivors of refractory cardiovascular collapse, J Thorac Cardiovasc Surg, 139, 10.1016/j.jtcvs.2009.11.018 Peek, 2009, Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentrerandomised controlled trial, Lancet, 374, 1351, 10.1016/S0140-6736(09)61069-2